CIK 0001610853 · Non-accelerated filer<br>Smaller reporting company
Solana Co
Sign in to watch- Ticker
- HSDT
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364787690
- Phone
- 215-944-6100
- Business address
- 1650 MARKET STREET, SUITE 3600, PHILADELPHIA, PA, 19103
- Former names
- HELIUS MEDICAL TECHNOLOGIES, INC., HELIUS MEDICAL TECHNOLOGIES, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Perkins Sherrie L Director | Grant or award · Stock Option (Right to Buy) | +23,529 | 23,529 | ||
| 2026-03-31 | Walter Blane Director | Grant or award | +2,180 | 95,634 | ||
| 2026-03-31 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +23,529 | 23,529 | ||
| 2026-03-31 | BUCKMAN PAUL Director | Grant or award | +2,180 | 92,004 | ||
| 2026-03-31 | BUCKMAN PAUL Director | Grant or award · Stock Option (Right to Buy) | +23,529 | 23,529 | ||
| 2026-03-31 | STRAW EDWARD M Director | Grant or award 10b5-1 | +2,180 | 92,291 | ||
| 2026-03-31 | STRAW EDWARD M Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +23,529 | 23,529 | ||
| 2025-09-18 | Jiang Cosmo Yi Director | Grant or award · Warrant (Right to Buy) | +1,005,040 | 1,005,040 | ||
| 2025-09-18 | Chee Choon Wee Executive Chairman | Grant or award · Strategic Advisory Warrants | +2,218,236 | 2,218,236 | ||
| 2025-07-02 | Favit-Van Pelt Antonella R. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-07-02 | MATHIESEN JEFFREY S CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +26,200 | 26,200 | ||
| 2025-07-02 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +2,600 | 2,600 | ||
| 2025-07-02 | STRAW EDWARD M Director | Grant or award · Stock Option (Right to Buy) | +2,600 | 2,600 | ||
| 2025-07-02 | BUCKMAN PAUL Director | Grant or award · Stock Option (Right to Buy) | +2,600 | 2,600 | ||
| 2025-07-02 | ANDREEFF DANE President and CEO | Grant or award · Stock Option (Right to Buy) | +52,400 | 52,400 | ||
| 2025-07-02 | Perkins Sherrie L Director | Grant or award · Stock Option (Right to Buy) | +2,600 | 2,600 | ||
| 2025-01-06 | MATHIESEN JEFFREY S CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +139,857 | 139,857 | ||
| 2025-01-06 | Perkins Sherrie L Director | Grant or award · Stock Option (Right to Buy) | +10,732 | 10,732 | ||
| 2025-01-06 | Favit-Van Pelt Antonella R. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +95,892 | 95,892 | ||
| 2025-01-06 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +10,732 | 10,732 |
Page 2 of 11 · 203 trades